Improvement in Serum Magnesium Levels With Sodium-Glucose Cotransporter 2 Inhibitors

Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are associated with a modest but significant increase in serum magnesium levels. This report describes improvement in serum magnesium and associated symptoms after initiating SGLT2i therapy in a patient with refractory hypomagnesemia. A 58-year-old...

Descripción completa

Detalles Bibliográficos
Autores principales: Saha, Arunava, Omer, Abdulkadir, Trivedi, Nitin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578385/
https://www.ncbi.nlm.nih.gov/pubmed/37908255
http://dx.doi.org/10.1210/jcemcr/luac018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578385/
https://www.ncbi.nlm.nih.gov/pubmed/37908255
http://dx.doi.org/10.1210/jcemcr/luac018

Ejemplares similares